Si ud. ha estado usando la solución ReNu para sus lentes de contacto y ha experimentado una herida de los ojos, posiblemente podría recibir compensación por su herida. Es muy importante que ud. consulte con un oftalmólogo inmediatamente. El doctor tiene que tomar una muestra de sus ojos para determinar si tiene el hongo fusarium keratitis. Favor de llamar a nuestra oficina para una consulta gratis.
Drug Products
Su ReNu Abogado
Si ud. ha estado usando la solución ReNu para sus lentes de contacto y ha experimentado una herida de los ojos, posiblemente podría recibir compensación por su herida. Es muy importante que ud. consulte con un oftalmólogo inmediatamente. El doctor tiene que tomar una muestra de sus ojos para determinar si tiene el hongo fusarium keratitis. Favor de llamar a nuestra oficina para una consulta gratis.
Ketek Raising Eyebrows
Ketek, a respiratory infection drug manufactured by Sanofi-Aventis and approved by the FDA in 2004, has been associated with severe liver damage. It’s not the first time the drug has caused controversy. The doctor who treated the most patients in the study, Maria “Anne” Kirkman Campbell, is in federal prison after pleading guilty to defrauding Aventis and others. An indictment says Dr. Campbell fabricated data she sent to the company. The documents show that Aventis was worried about Dr. Campbell early in study 3014 but didn’t tell the FDA until the agency’s own inspectors discovered the problem independently.
Bausch & Lomb Notified by Hong Kong Officials in Fall 2005
According to an article published in the Wall St. Journal, the maker of ReNu contact lens solution, was notified of eye infections in November 2005. The number of those infected with the fungus fusarium keratitits has now risen from 176 last week to 186 cases in 29 states. The product distributed in Singapore and Hong Kong is manufactured at the same South Carolina plant as product sold in the United States. The question remains why didn’t Bausch & Lomb publicize this information in November when it first learned of the problem.
Bausch & Lomb Lawsuit Filing Today
This afternoon I’ll be filing a civil lawsuit against Bausch & Lomb, the manufacturer of ReNu contact lens solution. I’ll be filing in US District Court for the Middle District of Florida on behalf of a woman who has lost nearly 80% of her vision in her left eye. Unfortunately, she is not a surgical candidate.
FDA Experts’ Conflicts of Interest
As a governmental oversight agency, it should be appalling that the FDA uses experts who have financial interests in the drugs and products about which they provide expert testimony. Yet, in a study conducted by the consumer group Public Citizen, that is exactly what is happening. How can any expert provide unbiased testimony about a product in which they’ve bought stock or have some financial interest? That’s not true oversight, but profiteering at the expense of the consumer.
Vioxx According to Jurors
There’s an insightful article in the online version of the Wall St. Journalregarding what jurors think when it comes to the pharmaceutical giant Merck and their drug Vioxx. The article states that three things are important when it comes to prevailing in a lawsuit against the maker of Vioxx: 1)show the victim used Vioxx; 2)a believable plaintiff witness, and 3)risk factors galore.
Now, in my mind, the first two are no brainers for any trial attorney. But the third comes as a huge surprise and goes against the conventional wisdom. Until the latest Vioxx verdict in the McDarby case, it was generally thought that the best case involved a person who had the fewest risk factors. Yet, Mr. McDarby turned that thinking on its head. It just goes to prove that there are certain intangible factors in any trial. The human element always presents the possibility for surprise.
Court Documents Show Ortho McNeil Knew Ortho Evra Was Lethal
Documents have surfaced in litigation that show Ortho-McNeil has been analyzing the FDA’s death and injury reports on women using the Ortho Evra birth-control patch, and has charts that show a higher rate of blood clots and deaths in women on the patch when compared to women who take birth-control pills.
GAO Criticizes FDA on How it Handles Drugs
The Government Accountability Office has published a report sharply critical of the Food and Drug Administration. The report states that the organization is sometimes too slow in recognizing safety problems once drugs have gone to market. The GAO report also says the FDA does not have clear policies for addressing drug safety issues and that it sometimes excludes its best safety experts from important meetings.
ReNu Being Removed From Shelves-What’s Next?
As the Bausch & Lomb contact solution is being removed from store shelves all across the country, users of the ReNu with MoistureLoc can do several things: 1) they need to monitor the health of their eyes ie. beware of symptoms including blurry vision, pain or redness, excessive discharge and increased sensitivity to light, 2)obtain legal & medical advice promptly.